<!DOCTYPE html>

<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ophthalmic Nursing - Chapter 17: Ophthalmic Drugs</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true,
                tags: 'ams' // Use AMS numbering of equations
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>

<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="ophthalmic-nursing-chapter-16.html" class="nav-button ">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                        <span class="progress-text">Chapter 17 of 17</span>
                    </div>
                    <a href="appendix-1.html" class="nav-button ">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>


            <header class="section-header">
                <h1 class="section-title">Chapter 17 Ophthalmic Drugs</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: introduction -->
                <section id="introduction" class="content-section" aria-labelledby="section-heading-1">
                    <div class="content-card">
                        <p>This chapter gives brief details of drugs commonly used in ophthalmic practice.</p>
                    </div>
                </section>
                <!-- END: introduction -->

                <!-- START: mydriatics -->
                <section id="mydriatics" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">Mydriatics</span>
                    </h2>
                    <div class="content-card">
                        <p>Mydriatic drugs are used to dilate the pupil for the following purposes:</p>
                        <ul>
                            <li>Examination of the retina.</li>
                            <li>Maintain dilation of the pupil in uveitis, with corneal ulcers, severe corneal abrasions
                                and after surgery.</li>
                            <li>Break down posterior synaechiae which may be present in uveitis.</li>
                            <li>Allow a cataract to be extracted.</li>
                            <li>Enable retinal surgery to take place.</li>
                            <li>Improve vision when a nuclear cataract is present.</li>
                            <li>Refraction in children.</li>
                        </ul>
                        <p>There are two groups of mydriatics:</p>
                        <ol>
                            <li>Parasympatholytics, which cause pupillary dilation - mydriasis and cycloplegia -
                                paralysis of the ciliary muscle.</li>
                            <li>Sympathomimetics, which cause only mydriasis.</li>
                        </ol>
                        <h3 class="subsection-heading">Parasympatholytics</h3>
                        <p><strong>G. Atropine sulphate 0.5% or 1%; Oc Atropine sulphate 1%</strong></p>
                        <p>Derived from the belladonna plant.</p>
                        <ul>
                            <li><strong>Onset:</strong> 30 minutes.</li>
                            <li><strong>Duration:</strong> 7-14 days.</li>
                            <li><strong>Dosage:</strong> Usually once or twice a day - may be up to four times.</li>
                            <li><strong>Side effects</strong> can be local or as a result of systemic absorption:
                                <ul>
                                    <li>may cause an allergic reaction</li>
                                    <li>toxic effects especially in the elderly, including; tachycardia, confusion,
                                        drowsiness, hallucinations, thirst.</li>
                                </ul>
                            </li>
                        </ul>
                        <p><strong>Disadvantages:</strong></p>
                        <ul>
                            <li>not readily reversed by miotics</li>
                            <li>prolonged duration</li>
                            <li>may provoke acute glaucoma in eyes with narrow angles.</li>
                        </ul>
                        <p><strong>G. Homatropine hydrobromide 1% or 2%</strong></p>
                        <p>A man-made derivative of atropine.</p>
                        <ul>
                            <li><strong>Onset:</strong> 30 minutes.</li>
                            <li><strong>Duration:</strong> 24-48 hours.</li>
                            <li><strong>Dosage:</strong> two, three or four times a day.</li>
                        </ul>
                        <p><strong>Advantages:</strong></p>
                        <ul>
                            <li>can be reversed by pilocarpine</li>
                            <li>shorter duration than atropine.</li>
                        </ul>
                        <p>Side effects are similar to those for atropine.</p>
                        <p><strong>G. Cyclopentolate hydrochloride 0.5% or 1% (Mydrilate)</strong></p>
                        <ul>
                            <li><strong>Onset:</strong> 30 minutes.</li>
                            <li><strong>Duration:</strong> 24 hours.</li>
                            <li><strong>Dosage:</strong> two, three or four times a day.</li>
                            <li><strong>Uses:</strong> often used in refraction of children. Pre- and post-operatively.
                            </li>
                        </ul>
                        <p>Side effects are similar to those for atropine.</p>
                        <p><strong>G. Tropicamide 0.5% or 1% (Mydriacyl)</strong></p>
                        <ul>
                            <li><strong>Onset:</strong> 20 minutes.</li>
                            <li><strong>Duration:</strong> six hours.</li>
                            <li><strong>Dosage:</strong> usually only once before examination because of its short-lived
                                effect.</li>
                        </ul>
                        <p><strong>Advantage:</strong> short duration makes it suitable for ophthalmoscopy in outpatient
                            or casualty patients.</p>
                        <p>Side effects are similar to those for atropine.</p>
                        <h3 class="subsection-heading">Sympathomimetics</h3>
                        <p><strong>G. Phenylephrine 2.5%</strong></p>
                        <ul>
                            <li><strong>Onset:</strong> 20 minutes.</li>
                            <li><strong>Duration:</strong> three hours.</li>
                            <li><strong>Dosage:</strong> two, three or four times daily, or up to four-hourly to break
                                down posterior synaechiae.</li>
                            <li><strong>Use:</strong> effective in combination with parasympatholytics, especially in
                                the breaking down of posterior synaechiae.</li>
                        </ul>
                        <p><strong>Disadvantages:</strong></p>
                        <ul>
                            <li>it does not cause cycloplegia</li>
                            <li>it can cause corneal epithelial damage</li>
                            <li>may cause cardiovascular reactions that may be severe.</li>
                        </ul>
                        <p>Some ophthalmologists may still prescribe G. phenylephrine 10%, but because of side effects
                            it is rarely used.</p>
                        <aside class="callout note" role="note">
                            <h4 class="callout-title"><span class="callout-icon"> </span>Notes on mydriatics</h4>
                            <ul>
                                <li>Mydriatics must be used with care in patients who have shallow anterior chambers as
                                    dilating the pupils may provoke an attack of closed-angle glaucoma.</li>
                                <li>All mydriatics drops sting on instillation to some degree. Phenylephrine usually
                                    causes the most discomfort.</li>
                            </ul>
                        </aside>
                    </div>
                </section>
                <!-- END: mydriatics -->

                <!-- START: miotics -->
                <section id="miotics" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">Miotics</span>
                    </h2>
                    <div class="content-card">
                        <p>Miotic drugs constrict the pupil and the ciliary muscle, which opens up the drainage channel
                            for aqueous flow. Therefore their main use is in the treatment of glaucoma.</p>
                        <p><strong>G. Pilocarpine 0.5%, 1%, 3%, 4%</strong> (may be up to 10% in other parts of the
                            world)</p>
                        <p>A natural compound from the pilocarpes tree found in South America. It is a
                            parasympathomimetic.</p>
                        <ul>
                            <li><strong>Onset:</strong> 30 minutes.</li>
                            <li><strong>Duration:</strong> 10-12 hours.</li>
                            <li><strong>Dosage:</strong> two, three or four times a day, or intensively for acute
                                glaucoma.</li>
                        </ul>
                        <p><strong>Disadvantages:</strong></p>
                        <ul>
                            <li>can cause headaches</li>
                            <li>the eye is fixed at accommodation</li>
                            <li>the pupil remains permanently miosed, increasing the risk of accidents especially at
                                night as light adaptation is restricted</li>
                            <li>care must be taken when used intensively as overdose can cause vomiting</li>
                            <li>may cause an allergic reaction</li>
                            <li>can sting on instillation.</li>
                        </ul>
                        <p><strong>Acetylcholine chloride 1% (Miochol)</strong></p>
                        <p>A freshly prepared solution of acetylcholine is injected into the anterior chamber after a
                            cataract extraction to constrict the pupil rapidly to prevent vitreous loss, or to retain a
                            posterior chamber or iris clip intra-ocular lens in position.</p>
                    </div>
                </section>
                <!-- END: miotics -->

                <!-- START: other-glaucoma-drugs -->
                <section id="other-glaucoma-drugs" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">Other drugs used in the treatment of glaucoma</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Carbonic anhydrase inhibitors</h3>
                        <p>Carbonic anhydrase is an enzyme necessary for the production of aqueous. These drugs
                            therefore cause a reduction in the amount of aqueous produced.</p>
                        <p><strong>Acetazolamide (Diamox)</strong></p>
                        <ul>
                            <li><strong>Dosage:</strong>
                                <ul>
                                    <li>500 mg intravenously stat in acute glaucoma</li>
                                    <li>500 mg orally stat</li>
                                    <li>250 mg orally as maintenance four times a day reducing to three or two doses a
                                        day or slow release capsules 250 mg given once or twice a day.</li>
                                </ul>
                            </li>
                            <li><strong>Uses:</strong> in acute, chronic and secondary glaucoma.</li>
                            <li><strong>Side effects:</strong> drowsiness, gastro-intestinal upset, nausea and potassium
                                loss resulting in tingling of extremities. Potassium supplements such as potassium
                                chloride are sometimes given. It is a weak diuretic.</li>
                        </ul>
                        <p><strong>G. Dorzolamide 2% (Trusopt)</strong></p>
                        <ul>
                            <li><strong>Dosage:</strong> three times a day, or twice a day if given with a beta-blocker.
                            </li>
                            <li><strong>Use:</strong> in chronic and secondary glaucoma as an adjuvant therapy to
                                betablockers or as a single therapy to non-responders or in those who are unable to
                                tolerate beta-blockers.</li>
                            <li><strong>Side effects:</strong> conjunctivitis, eyelid irritation.</li>
                        </ul>
                        <p><strong>G. Dorzolomide 2% and Timolol 0.5% (Cosopt)</strong></p>
                        <ul>
                            <li><strong>Dosage:</strong> twice per day. Timolol is a beta-blocker.</li>
                            <li><strong>Use:</strong> to reduce intra-ocular pressure in open-angle glaucoma.</li>
                        </ul>
                        <h3 class="subsection-heading">Beta-blockers</h3>
                        <p><strong>G. Timolol maleate 0.25% or 0.5% (Timoptol)</strong><br>
                            <strong>G. Betaxolol hydrochloride 0.5% (Betoptic)</strong><br>
                            <strong>G. Carteolol hydrochloride 1% or 2% (Teoptic)</strong><br>
                            <strong>G. Levobunolol hydrochloride 0.5% (Betagan)</strong>
                        </p>
                        <ul>
                            <li><strong>Actions:</strong> reduce the production of aqueous and after several weeks use
                                increase the outflow of aqueous.</li>
                            <li><strong>Dosage:</strong> 12 hourly, strictly (betagan may be used daily).</li>
                        </ul>
                        <p><strong>Advantages:</strong> do not cause miosis or accommodation spasm.</p>
                        <p><strong>Disadvantages:</strong> cannot be used in patients with a history of asthma or
                            congestive cardiac failure.</p>
                        <p>Timolol and levobunolol are available in single dose presentations.</p>
                        <h3 class="subsection-heading">Prostaglandin analogues</h3>
                        <ul>
                            <li><strong>Actions:</strong> prostaglandin analogues reduce the intra-ocular pressure by
                                increasing the uveoscleral outflow. They are used to treat open angle glaucoma and
                                ocular hypertension.</li>
                            <li><strong>Disadvantages:</strong> the patient needs to be warned that this drug may change
                                the colour of their iris. Caution should be taken if the patient has asthma.</li>
                            <li><strong>Side effects include:</strong> brown pigment on the iris; irritation;
                                lengthening of the eyelashes; peri-orbital oedema; cystoid macular oedema; iritis;
                                uveitis.</li>
                        </ul>
                        <p><strong>G. Latanaprost (Xalatan) 50 $\mu\text{g}$ per ml</strong></p>
                        <ul>
                            <li><strong>Use:</strong> once per day, ideally in the evening.</li>
                        </ul>
                        <p><strong>G. Travaprost (Travatan) 40 $\mu\text{g}$ per ml</strong></p>
                        <ul>
                            <li><strong>Use:</strong> once per day, ideally in the evening.</li>
                        </ul>
                        <p><strong>G. Bimatoprost (Lumigan) 300 $\mu\text{g}$ per ml</strong></p>
                        <ul>
                            <li><strong>Use:</strong> once per day, ideally in the evening.</li>
                        </ul>
                        <h3 class="subsection-heading">Other drugs</h3>
                        <p><strong>Mannitol 20%</strong></p>
                        <ul>
                            <li><strong>Use:</strong> given intravenously in acute glaucoma when acetazolamide has
                                failed to reduce the intra-ocular pressure. It can be given pre-operatively. Usually
                                $1.5-2\text{ g/kg}$ body weight is given over one hour.</li>
                        </ul>
                        <p><strong>Glycerol</strong></p>
                        <ul>
                            <li><strong>Action:</strong> an osmotic.</li>
                            <li><strong>Use:</strong> oral dose given in acute glaucoma when acetazolamide has failed to
                                reduce the intra-ocular pressure.</li>
                            <li><strong>Dosage:</strong> $1.5\text{ g/kg}$ body weight in fruit juice to disguise the
                                taste. It must be drunk within 20 minutes to affect the intra-ocular pressure. Topical
                                glycerol 50% can be used to clear corneal oedema temporarily for ophthalmoscopy to take
                                place.</li>
                        </ul>
                        <p><strong>G. Apraclonidine hydrochloride 0.5% and 1% (Iopidine)</strong></p>
                        <ul>
                            <li><strong>Action:</strong> reduces production of aqueous.</li>
                            <li><strong>Use:</strong> adjunctive therapy in chronic glaucoma.</li>
                            <li><strong>Dosage:</strong> three times a day.</li>
                            <li><strong>Side effects:</strong> it is contraindicated in patients with severe or unstable
                                cardiovascular disease, those receiving monoamine oxidase inhibitors, sympathomimetic
                                drugs and tricyclic antidepressants. Localised allergy.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: other-glaucoma-drugs -->
            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="ophthalmic-nursing-chapter-16.html" class="nav-button ">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                        <span class="progress-text">Chapter 17 of 17</span>
                    </div>
                    <a href="appendix-1.html" class="nav-button ">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>

</html>